1/14
05:02 pm
teva
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
Low
Report
AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine
1/13
07:46 pm
teva
Is It Too Late To Reassess Teva (TEVA) After A 55% One Year Rally? [Yahoo! Finance]
Low
Report
Is It Too Late To Reassess Teva (TEVA) After A 55% One Year Rally? [Yahoo! Finance]
1/13
07:07 pm
teva
Public advisory -Teva Octreotide for injectable suspension recalled due to potential drug quality issues [Yahoo! Finance]
Low
Report
Public advisory -Teva Octreotide for injectable suspension recalled due to potential drug quality issues [Yahoo! Finance]
1/11
07:40 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation [Yahoo! Finance]
Low
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation [Yahoo! Finance]
1/11
06:00 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
Low
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering Growth and Transforming through Innovation
1/11
05:13 pm
teva
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo [Yahoo! Finance]
Low
Report
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo [Yahoo! Finance]
1/11
05:00 pm
teva
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
Low
Report
Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
1/11
08:22 am
teva
Teva Pharmaceutical Industries Limited's (NYSE:TEVA) high institutional ownership speaks for itself as stock continues to impress, up 3.4% over last week [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries Limited's (NYSE:TEVA) high institutional ownership speaks for itself as stock continues to impress, up 3.4% over last week [Yahoo! Finance]
1/10
01:07 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at
W
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at
W
1/7
04:26 am
teva
How Investors Are Reacting To Teva (TEVA) Earnings Beat And New Schizophrenia And Osteoporosis Drugs [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Teva (TEVA) Earnings Beat And New Schizophrenia And Osteoporosis Drugs [Yahoo! Finance]
1/6
09:29 pm
teva
How Recent Guidance And Price Targets Are Reframing The Story For Teva Pharmaceutical Industries (NYSE:TEVA) [Yahoo! Finance]
Low
Report
How Recent Guidance And Price Targets Are Reframing The Story For Teva Pharmaceutical Industries (NYSE:TEVA) [Yahoo! Finance]
1/6
02:53 pm
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Jefferies Financial Group Inc. from $29.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Jefferies Financial Group Inc. from $29.00 to $40.00. They now have a "buy" rating on the stock.
1/6
11:03 am
teva
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Recent Share Price Momentum [Yahoo! Finance]
1/5
05:07 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/5
04:30 pm
teva
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/5
03:07 pm
teva
Bleichmar Fonti & Auld LLP Announces New Partners [Yahoo! Finance]
Low
Report
Bleichmar Fonti & Auld LLP Announces New Partners [Yahoo! Finance]
12/30
12:17 am
teva
What Do Analysts Think About Teva Pharmaceutical Industries (TEVA)? [Yahoo! Finance]
Low
Report
What Do Analysts Think About Teva Pharmaceutical Industries (TEVA)? [Yahoo! Finance]
12/26
01:51 pm
teva
This International Pharma Stock Just Hit 5-Year Highs [Yahoo! Finance]
Low
Report
This International Pharma Stock Just Hit 5-Year Highs [Yahoo! Finance]
12/24
04:31 pm
teva
S&P Global Ratings Upgrades Teva to ‘BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive [Yahoo! Finance]
Low
Report
S&P Global Ratings Upgrades Teva to ‘BB+' Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive [Yahoo! Finance]
12/24
08:36 am
teva
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
Low
Report
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive
12/22
08:02 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Piper Sandler from $30.00 to $40.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at Piper Sandler from $30.00 to $40.00. They now have an "overweight" rating on the stock.
12/21
09:10 am
teva
Teva Pharmaceutical Industries' (NYSE:TEVA) investors will be pleased with their impressive 228% return over the last three years [Yahoo! Finance]
Low
Report
Teva Pharmaceutical Industries' (NYSE:TEVA) investors will be pleased with their impressive 228% return over the last three years [Yahoo! Finance]
12/19
12:22 pm
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $31.00 to $35.00. They now have a "buy" rating on the stock.
12/19
03:40 am
teva
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
Low
Report
Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®
12/16
11:08 am
teva
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $28.00 to $35.00. They now have an "overweight" rating on the stock.
Low
Report
Teva Pharmaceutical Industries (NYSE:TEVA) had its price target raised by analysts at JPMorgan Chase & Co. from $28.00 to $35.00. They now have an "overweight" rating on the stock.